{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T21:09:06Z","timestamp":1788815346376,"version":"build-2803163510"},"reference-count":38,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ijgc.2026.104950","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T09:15:55Z","timestamp":1788254155000},"page":"104950","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["International Papillomavirus Society statement on reputed treatments for human papillomavirus infection and human papillomavirus-related diseases: evidence, risks, and standards for clinical evaluation"],"prefix":"10.1016","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2498-5206","authenticated-orcid":false,"given":"Laila Sara","family":"Arroyo M\u00fchr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chemtai","family":"Mungo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5357-4708","authenticated-orcid":false,"given":"Kimon","family":"Chatzistamatiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuk On Annie","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne M.","family":"Garland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laila Sara","family":"Arroyo M\u00fchr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prajakta","family":"Adsul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neerja","family":"Bhatla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F Xavier","family":"Bosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Brotherton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimon","family":"Chatzistamatiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne M.","family":"Garland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas M.","family":"Kaufmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuk On","family":"Annie Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woo Yin","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Barbara","family":"Moscicki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chemtai","family":"Mungo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia Maria","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Wentzensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ijgc.2026.104950_bib1","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/ijc.30716","article-title":"Worldwide burden of cancer attributable to HPV by site, country and HPV type","volume":"141","author":"de Martel","year":"2017","journal-title":"Int J Cancer"},{"issue":"12","key":"10.1016\/j.ijgc.2026.104950_bib2","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.29332","article-title":"The International human papillomavirus Reference Center: standardization, collaboration, and quality assurance in HPV research and diagnostics","volume":"95","author":"Arroyo M\u00fchr","year":"2023","journal-title":"J Med Virol."},{"issue":"10451","key":"10.1016\/j.ijgc.2026.104950_bib3","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0140-6736(24)01097-3","article-title":"Causal attribution of human papillomavirus genotypes to invasive cervical cancer worldwide: a systematic analysis of the global literature","volume":"404","author":"Wei","year":"2024","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.ijgc.2026.104950_bib4","first-page":"322","article-title":"Global burden of cervical cancer: current estimates, temporal trend and future projections based on the GLOBOCAN 2022","volume":"5","author":"Wu","year":"2025","journal-title":"J Natl Cancer Cent"},{"issue":"7","key":"10.1016\/j.ijgc.2026.104950_bib5","doi-asserted-by":"crossref","first-page":"e453","DOI":"10.1016\/S2214-109X(16)30099-7","article-title":"Global estimates of human papillomavirus vaccination coverage by region and income level: a pooled analysis","volume":"4","author":"Bruni","year":"2016","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.ijgc.2026.104950_bib6","unstructured":"WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention. 2nd ed. World Health Organization. Accessed March 4, 2026. https:\/\/www.who.int\/publications\/i\/item\/9789240030824."},{"issue":"3","key":"10.1016\/j.ijgc.2026.104950_bib7","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/LGT.0000000000000806","article-title":"A scoping review of complementary and alternative medicine for human papillomavirus infections and cervical dysplasia","volume":"28","author":"Walsh","year":"2024","journal-title":"J Low Genit Tract Dis"},{"issue":"1","key":"10.1016\/j.ijgc.2026.104950_bib8","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/sj.bjc.6603210","article-title":"HPV testing in routine cervical screening: cross sectional data from the ARTISTIC trial","volume":"95","author":"Kitchener","year":"2006","journal-title":"Br J Cancer"},{"issue":"8","key":"10.1016\/j.ijgc.2026.104950_bib9","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1111\/1471-0528.17058","article-title":"Age-specific outcomes from the first round of HPV screening in unvaccinated women: observational study from the English cervical screening pilot","volume":"129","author":"Rebolj","year":"2022","journal-title":"BJOG"},{"issue":"12","key":"10.1016\/j.ijgc.2026.104950_bib10","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1086\/657321","article-title":"Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings","volume":"202","author":"Bruni","year":"2010","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.ijgc.2026.104950_bib11","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/jnci\/djx145","article-title":"Use of alternative medicine for cancer and its impact on survival","volume":"110","author":"Johnson","year":"2018","journal-title":"J Natl Cancer Inst"},{"issue":"suppl 1","key":"10.1016\/j.ijgc.2026.104950_bib12","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/rmv.1822","article-title":"Human papillomavirus molecular biology and disease association","volume":"25","author":"Doorbar","year":"2015","journal-title":"Rev Med Virol"},{"issue":"6","key":"10.1016\/j.ijgc.2026.104950_bib13","first-page":"954","article-title":"Vaginal 5-fluorouracil for high-grade cervical dysplasia in human immunodeficiency virus infection: a randomized trial","volume":"94","author":"Maiman","year":"1999","journal-title":"Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.ijgc.2026.104950_bib14","doi-asserted-by":"crossref","first-page":"314.e1","DOI":"10.1016\/j.ajog.2013.12.042","article-title":"Topical 5-fluorouracil for treatment of cervical intraepithelial neoplasia 2: a randomized controlled trial","volume":"210","author":"Rahangdale","year":"2014","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.ijgc.2026.104950_bib15","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1097\/AOG.0000000000004384","article-title":"Topical imiquimod for the treatment of high-grade squamous intraepithelial lesions of the cervix: a randomized controlled trial","volume":"137","author":"Fonseca","year":"2021","journal-title":"Obstet Gynecol"},{"issue":"8","key":"10.1016\/j.ijgc.2026.104950_bib16","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.3390\/cancers16081610","article-title":"Imiquimod is effective in reducing cervical intraepithelial neoplasia: a systematic review and meta-analysis","volume":"16","author":"Hamar","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.ijgc.2026.104950_bib17","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/ijgo.14953","article-title":"The efficacy of topical imiquimod in high-grade cervical intraepithelial neoplasia: a systematic review and meta-analysis","volume":"164","author":"van de Sande","year":"2024","journal-title":"Int J Gynaecol Obstet"},{"issue":"4","key":"10.1016\/j.ijgc.2026.104950_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7004a1","article-title":"Sexually transmitted infections treatment guidelines, 2021","volume":"70","author":"Workowski","year":"2021","journal-title":"MMWR Recomm Rep"},{"issue":"21","key":"10.1016\/j.ijgc.2026.104950_bib19","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000010864","article-title":"Efficacy and safety of photodynamic therapy for cervical intraepithelial neoplasia and human papilloma virus infection: a systematic review and meta-analysis of randomized clinical trials","volume":"97","author":"Zhang","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ijgc.2026.104950_bib20","doi-asserted-by":"crossref","DOI":"10.2340\/actadv.v104.40819","article-title":"Efficacy of intralesional candida injection in the treatment of cutaneous warts: a systematic review and meta-analysis","volume":"104","author":"Chang","year":"2024","journal-title":"Acta Derm Venereol"},{"issue":"3","key":"10.1016\/j.ijgc.2026.104950_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.xjidi.2024.100264","article-title":"Systematic review of intralesional therapies for cutaneous warts","volume":"4","author":"Mullen","year":"2024","journal-title":"JID Innov."},{"issue":"10","key":"10.1016\/j.ijgc.2026.104950_bib22","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.36849\/JDD.7258","article-title":"Cidofovir in the management of non-genital warts: a review","volume":"22","author":"Cook","year":"2023","journal-title":"J Drugs Dermatol."},{"issue":"4","key":"10.1016\/j.ijgc.2026.104950_bib23","doi-asserted-by":"crossref","first-page":"428","DOI":"10.3390\/vaccines12040428","article-title":"Therapeutic vaccines for HPV-associated cervical malignancies: a systematic review","volume":"12","author":"Alouini","year":"2024","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.ijgc.2026.104950_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2025.104721","article-title":"Novel therapeutic strategies for targeting E6 and E7 oncoproteins in cervical cancer","volume":"211","author":"Ranasinghe","year":"2025","journal-title":"Crit Rev Oncol Hematol."},{"issue":"1","key":"10.1016\/j.ijgc.2026.104950_bib25","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s12905-019-0798-y","article-title":"The influence of probiotics on genital high-risk human papilloma virus clearance and quality of cervical smear: a randomized placebo-controlled trial","volume":"19","author":"Ou","year":"2019","journal-title":"BMC Womens Health"},{"issue":"1","key":"10.1016\/j.ijgc.2026.104950_bib26","doi-asserted-by":"crossref","first-page":"9","DOI":"10.21037\/cco-25-100","article-title":"Clinical evidence on a Coriolus versicolor-based vaginal gel for HPV-related cervical disease: a narrative review","volume":"15","author":"S\u00e1nchez","year":"2026","journal-title":"Chin Clin Oncol."},{"key":"10.1016\/j.ijgc.2026.104950_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.cct.2026.108272","article-title":"Randomized clinical trial protocol: acceptability and feasibility of combination treatment for cervical precancer among South African women living with HIV (ACT 2)","volume":"164","author":"Chibwesha","year":"2026","journal-title":"Contemp Clin Trials"},{"issue":"5","key":"10.1016\/j.ijgc.2026.104950_bib28","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1086\/322593","article-title":"Phase II double-blind, placebo-controlled study of the safety and efficacy of cidofovir topical gel for the treatment of patients with human papillomavirus infection","volume":"33","author":"Snoeck","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.ijgc.2026.104950_bib29","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.ogc.2022.08.008","article-title":"Prevention of cervical cancer in low-resource African settings","volume":"49","author":"Mulongo","year":"2022","journal-title":"Obstet Gynecol Clin North Am"},{"issue":"10","key":"10.1016\/j.ijgc.2026.104950_bib30","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1001\/jamaoncol.2021.2683","article-title":"Human papillomavirus persistence and association with recurrent cervical intraepithelial neoplasia after cryotherapy vs loop electrosurgical excision procedure among HIV-positive women: a secondary analysis of a randomized clinical trial","volume":"7","author":"Chung","year":"2021","journal-title":"JAMA Oncol"},{"issue":"12","key":"10.1016\/j.ijgc.2026.104950_bib31","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1002\/ijc.34737","article-title":"Efficacy of thermal ablation for treatment of biopsy-confirmed high-grade cervical precancer among women living with HIV in Kenya","volume":"153","author":"Mungo","year":"2023","journal-title":"Int J Cancer"},{"issue":"7","key":"10.1016\/j.ijgc.2026.104950_bib32","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1046\/j.1365-2230.2002.01151.x","article-title":"Imiquimod and the imidazoquinolones: mechanism of action and therapeutic potential","volume":"27","author":"Stanley","year":"2002","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.ijgc.2026.104950_bib33","unstructured":"Human papillomavirus infection and treatment. Essential Programme. Generalitat de Catalunya. Accessed February 28, 2026. https:\/\/essencialsalut.gencat.cat\/en\/detalls\/Article\/infeccio-vph-tractamen."},{"issue":"25","key":"10.1016\/j.ijgc.2026.104950_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2024.07.001","article-title":"Meeting report: Considerations for trial design and endpoints in licensing therapeutic HPV16\/18 vaccines to prevent cervical cancer","volume":"42","author":"Dull","year":"2024","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.ijgc.2026.104950_bib35","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1099\/vir.0.039677-0","article-title":"Genital human papillomavirus infections: current and prospective therapies","volume":"93","author":"Stanley","year":"2012","journal-title":"J Gen Virol"},{"key":"10.1016\/j.ijgc.2026.104950_bib36","unstructured":"Health Technology Assessment evaluation framework. Ag\u00e8ncia de Qualitat i Avaluaci\u00f3 Sanit\u00e0ries de Catalunya (AQuAS). Accessed March 4, 2026. https:\/\/aquas.gencat.cat\/web\/.content\/minisite\/aquas\/publicacions\/2023\/infografia_evaluacion_tecnologias_sanitarias_aquas2022es.pdf."},{"issue":"7650","key":"10.1016\/j.ijgc.2026.104950_bib37","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.ijgc.2026.104950_bib38","series-title":"Clinical Practice Guidelines We Can Trust","year":"2011"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X26004810?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X26004810?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T20:46:10Z","timestamp":1788813970000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X26004810"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":38,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S1048891X26004810"],"URL":"https:\/\/doi.org\/10.1016\/j.ijgc.2026.104950","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"International Papillomavirus Society statement on reputed treatments for human papillomavirus infection and human papillomavirus-related diseases: evidence, risks, and standards for clinical evaluation","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijgc.2026.104950","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of European Society of Gynaecological Oncology and the International Gynecologic Cancer Society.","name":"copyright","label":"Copyright"}],"article-number":"104950"}}